Patent Yard Sign in
Canadian application, no grantCanada

Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis

CA 2268013 A1 · Owner: Barthold, Stephen W. · Inventors: Fikrig, Erol; Barthold, Stephen W.; Sun, Wei

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Methods and compositions for the prevention treatment and diagnosis of human , granulocytic ehrlichiosis. aoHGE polypeptides serotypic variants thereof, fragments thereof and derivatives thereof. Fusion proteins and multimeric proteins comprising same. Vaccines comprising aoHGE polypeptides alone or in addition to other protective aoHGE polypeptides. DNA sequences recombinant , DNA molecules and transformed host cells useful in the compositions and methods. Antibodies directed against the aoHGE polypeptides and diagnostic , kits comprising the polypeptides or antibodies.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 30, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 30, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 30, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 30, 1997
GrantedNo grant recorded
Term endedSeptember 30, 2017
Patent numberCA 2268013 A1
Classification (IPC)C12N15/31 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedSep 30, 1997Term endedSep 30, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.